Health
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised – Mirage News
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at…
Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and direct those who test positive for infection to dedicated wards. A recent study showed that SAMBA II, a new point-of-care PCR test for SARS-CoV-2 developed by Cambridge researchers, was able to dramatically reduce time spent on COVID-19 ‘holding’ wards – allowing patients to be treated or discharged far quicker than with c…
-
Business12 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General9 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business11 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?